The trace element selenium and the thyroid gland

Biochimie

Volumn 81, Issue 5, 1999, Pages 527-533

  Köhrle, Josef ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cell defence; Deiodinase; Iodine; Selenium; Selenoprotein; Thyroid

Indexed keywords

GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; IODINE; REACTIVE OXYGEN METABOLITE; SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE;

ARTICLE; CONGENITAL HYPOTHYROIDISM; HASHIMOTO DISEASE; THYROID ADENOMA; THYROID CARCINOMA; THYROID CELL; THYROID GLAND; THYROID HORMONE METABOLISM; THYROID HORMONE SYNTHESIS;

ANIMALIA;

EID: 0038501459     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80105-9     Document Type: Article

References (81)

1. Schwarz K., Foltz C.M. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79:1957;3292-3293.
2. Vernie L.N. Selenium in carcinogenesis. Biochim. Biophys. Acta. 738:1984;203-217.
3. Flohé L., Günzler W., Schock H.H. Glutathione peroxidase: a selenoenzyme. FEBS Lett. 32:1973;132-134.
4. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science. 179:1973;588-590.
5. Böck A., Forchhammer K., Heider J., Leinfelder W., Sawers G., Veprek B., Zinoni F. Selenocysteine: the 21st amino acid. Mol. Microbiol. 5:1991;515-520.
6. Stadtman T.C. Selenocysteine. Annu. Rev. Biochem. 65:1996;83-100.
7. Guimaraes M.J., Peterson D., Vicari A., Cocks B.G., Copeland N.G., Gilbert D.J., Jenkins N.A., Ferrick D.A., Kastelein R.A., Bazan J.F., Zlotnik A. Identification of a novel selD homolog from eukaryotes, bacteria, and archeae: is there an autoregulatory mechanism in selenocysteine metabolism? Proc. Natl. Acad. Sci. USA. 93:1996;15086-15091.
8. Low S.C., Berry M.J. Knowing when not to stop: selenocysteine incorporation in eucaryotes. TIBS. 21:1996;203-208.
9. Huttenhofer A., Westhof E., Böck A. Solution structure of mRNA hairpins promoting selenocysteine incorporation in Escherichia coli and their base-specific interaction with special elongation factor SELB. RNA. 2:1996;354-366.
10. Walczak R., Westhof E., Carbon P., Krol A. A novel RNA structural motif in the selenocysteine insertion element of eukaryotic selenoprotein mRNAs. RNA. 2:1996;367-379.
11. Shen Q., Wu R., Leonard J.L., Newburger P.E. Identification and molecular cloning of a human selenocysteine insertion sequence-binding protein. J. Biol. Chem. 273:1998;5443-5446.
12. Lee B.J., Park S.I., Park J.M., Chittum H.S., Hatfield D.L. Molecular biology of selenium and its role in human health. Mol. Cell. 6:1996;509-520.
13. Ishii Y., Hatsumura M., Ishida T., Ariyoshi N., Oguri K. Significant induction of a 54-kDa protein in rat liver with homologous alignment to mouse selenium binding protein by a coplanar polychlorinated biphenyl, 3,4,5,3',4'-pentachlorobiphenyl and 3-methylcholanthrene. Toxicol. Lett. 87:1996;1-9.
14. Chang P.W.G., Tsui S.K.W., Liew C.C., Lee C.Y., Waye M.M.Y., Fung K.P. Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J. Cell. Biochem. 64:1997;217-224.
15. Behne D., Weiss Nowak C., Kalcklösch M., Westphal C., Gessner H., Kyriakopoulos A. Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst. 120:1995;823-825.
16. Behne D., Kyriakopoulos A., Meinhold H., Köhrle J. Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme. Biochem. Biophys. Res. Commun. 173:1990;1143-1149.
17. Arthur J.R., Nicol F., Beckett G.J. Hepatic iodothyronine 5'-deiodinase. The role of selenium. Biochem. J. 272:1990;537-540.
18. Berry M.J., Banu L., Larsen P.R. Type I iodothyronine deiodinase is a selenocystein-containing enzyme. Nature. 349:1991;438-440.
19. Gross J., Pitt-Rivers R. The identification of 3,5,3'-triiodothyronine in human plasma. Lancet. I:1952;439-441.
20. Pitt-Rivers R., Stanbury J.B., Rapp B. Conversion of thyroxine to 3,5,3'-triiodothyronine in vivo. J. Clin. Endocrinol. 15:1955;616-620.
21. Braverman L.E., Ingbar S.H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic subjects. J. Clin. Invest. 49:1970;855-864.
22. Hesch R.D., Brunner G., Soeling H.D. Conversion of thyroxine (T4) and triiodothyronine (T3) and the subcellular localisation of the converting enzyme. Clin. Chim. Acta. 59:1975;209-213.
23. Visser T.J., van der Does-Tobe I., Docter R., Hennemann G. Conversion of thyroxine into tri-iodothyronine by rat liver homogenate. Biochem. J. 150:1975;489-493.
24. Galton V.A., Schneider M.J., Becker K.B., Davey J.C. The type III 5-deiodinase in Rana catesbeiana (RC) tadpoles is encoded by a thyroid hormone-responsive gene. Thyroid. 4:1994;S96. abstract.
25. StGermain D.L., Schwartzman R.A., Croteau W., Kanamori A., Wang Z., Brown D.D., Galton V.A. A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase. Proc. Natl. Acad. Sci. USA. 91:1994;11282.
26. Salvatore D., Low S.C., Berry M., Maia A.L., Harney J.W., Croteau W., StGermain D.L., Larsen P.R. Type 3 iodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J. Clin. Invest. 96:1995;2421-2430.
27. Van DerGeyten S., Sanders J.P., Kaptein E., Darras V.M., Kühn E.R., Leonard J.L., Visser T.J. Expression of chicken hepatic type I and type III iodothyronine deiodinases during embryonic development. Endocrinology. 138:1997;5144-5152.
28. Davey J.C., Becker K.B., Schneider M.J., StGermain D.L., Galton V.A. Cloning of a cDNA for the type II iodothyronine deiodinase. J. Biol. Chem. 270:1995;26786-26789.
29. Becker K.B., Stephens K.C., Davey J.C., Schneider M.J., Galton Y.A. The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating developement in Rana catesbeiana tadpoles. Endocrinology. 138:1997;2989-2997.
30. Valverde R.C., Croteau W., Lafleur G.J., Orozco A., Germain D.L.S. Cloning and expression of a 5'-iodothyronine deiodinase from the liver of Fundulus heteroclitus, Endocrinology. 138:1997;642-648.
31. Salvatore D., Bartha T., Harney J.W., Larsen P.R. Molecular biological and biochemical charcterization of the human type 2 selenodeiodinase. Endocrinology. 137:1996;3308-3315.
32. Croteau W., Davey J.C., Galton V.A., St. Germain D.L. Cloning of the mammalian type II iodothyronine deiodinase. J. Clin. Invest. 98:1996;405-417.
33. Berry M.J., Kieffer J.D., Larsen P.R. Evidence that cysteine, not selenocysteine, is in the catalytic site of type II iodothyronine deiodinase. Endocrinology. 129:1991;550-552.
34. Koopdonk Kool J.M., De Vijlder J.J., Veenboer G.J., Ris Stalpers C., Kok J.H., Vulsma T., Boer K., Visser T.J. Type II and type III deiodinase activity in human placenta as a function of gestational age. J. Clin. Endocrinol. Metab. 81:1996;2154-2158.
35. Visser T.J. Pathways of thyroid hormone metabolism. Acta Med Austriaca. 23:1996;10-16.
36. Safran M., Farwell A.P., Leonard J.L. Evidence that type II 5'-deiodinase is not a selenoprotein. J. Biol. Chem. 266:1991;13477-13480.
37. Chanoine J.P., Safran M., Farwell A.P., Tranter P., Ekenbarger S.M., Dubord S., Alex S. Selenium deficiency and type II 5'-deiodinase regulation in the euthyroid and hypothyroid rat. Endocrinology. 130:1992;479-484.
38. Leonard J.L., Safran M., Farwell A.P. Type II iodothyronine deiodinase (IDII) in astrocytes is not encoded by the 7.5 kb IDII mRNA. Program & Abstracts 79th Annual Meeting The Endocrine Society. 1997;293. abstract.
39. Meinhold H., Campos-Barros A., Behne D. Effects of selenium and iodine deficiency on iodothyronine deiodinases in brain, thyroid and peripheral tissue. Acta Med. Austriaca. 19:1992;8-12.
40. Meinhold H., Campos-Barros A., Walzog B., Köhler R., Müller F., Behne D. Effects of selenium and iodine deficiency on Type I, Type II, and Type III iodothyronine deiodinases and circulating hormone levels in the rat. Exp. Clin. Endocrinol. 100:1993;87-93.
41. Pallud S., Lennon A.M., Ramauge M., Gavaret J.M., Croteau W., Pierre M., Courtin F., Germain D. Expression of the Type II iodothyronine deiodinase in cultured rat astrocytes is selenium-dependent. J. Biol. Chem. 272:1997;18104-18110.
42. Gross M., Oertel M., Köhrle J. Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1. Biochem. J. 306:1995;851-856.
43. Oertel M., Gross M., Rokos H., Köhrle J. Selenium-dependent regulation of type I 5'-deiodinase expression. Am. J. Clin. Nutr. 57:1993;313S-314S.
44. Köhrle J. Thyroid hormone deiodinases - a selenoenzyme family acting as gate keepers to thyroid hormone action. Acta Med. Austriaca. 23:1996;17-30.
45. Leonard J.L., Köhrle J. Intracellular pathways of iodothyronine metabolism. Braverman L.E, Utiger R.D. Werner and Ingbar's The Thyroid - A Fundamental and Clinical Text. 1996;125-161 Lippincott, Philadelphia.
46. Depalo D., Kinlaw W.B., Zhao C., Engelberg-Kulka H., StGermain D.L. Effect of selenium deficiency on type I 5'-deiodinase. J. Biol. Chem. 269:1994;16223-16228.
47. Salvatore D., Tu H., Harney J.W., Larsen P.R. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J. Clin. Invest. 98:1996;962-968.
48. Schreck R., Schnieders F., Schmutzler C., Köhrle J. Retinoids stimulate Type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 79:1994;791-798.
49. Köhrle J., Oertel M., Hoang-Vu C., Schnieders F., Brabant G. Type I 5'-deiodinase - a marker for differentiated thyroid carcinoma? Exp. Clin. Endocrinol. 101:1993;60-72.
50. Köhrle J. Thyroid carcinoma: Interrelationships between local thyroid hormone metabolism by the type I 5'-deiodinase and the expression of thyroid hormone receptors and other thyroid specific (de-) differentiation markers. Schmid K.W, Böcker W. Current topics in pathology. 1997;83-116 Springer Verlag, Berlin.
51. Moreno M., Berry M.J., Horst C., Thoma R., Goglia F., Harney J.W., Larsen P.R., Visser T.J. Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase. FEBS Lett. 344:1994;143-146.
52. Toyoda N., Kaptein E., Berry M.J., Harney J.W., Larsen P.R., Visser T.J. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Endocrinology. 138:1997;213-219.
53. Beech S.G., Walker S.W., Dorrance A.M., Arthur J.R., Nicol F., Lee D., Beckett G.J. The role of thyroidal type-I iodothyronine deiodinase in tri-iodothyronine production by human and sheep thyrocytes in primary culture. J. Endocrinol. 136:1993;361-370.
54. Jakobs T.C., Koehler M.R., Schmutzler C., Glaser F., Schmid M., Köhrle J. Structure of the human type I iodothyronine 5'-deiodinase gene and localization to chromosome 1p32-p33. Genomics. 42:1997;361-363.
55. Celi F.S., Canettieri G., Yarnall D.P., Burns D.K., Andreoli M., Shuldiner A.R., Centanni M. Genomic characterization of the coding region of the human type II 5'-deiodinase gene. Mol. Cell. Endocrinol. 14:1998;49-52.
56. Dickson R.C., Tomlinson R.H. Selenium in blood and human tissues. Clin. Chim. Acta. 16:1967;311-321.
57. Oster O., Schmiedel G., Prellwitz W. The organ distribution of selenium in German adults. Biol. Trace Elem. Res. 15:1988;23-45.
58. Köhrle J., Schmutzler C., Fekete E., Dreher I., Goretzki P., Simon D., Gawlik D., Behne D., Brabant G. The role of selenium in human thyroid carcinoma. Exp. Clin. Endocrinol. 103:1995;171. abstract.
59. Dreher I., Köhrle J. The role of selenium and selenoproteins in thyroid tissue. Thyroid. 6:1996;145.
60. Zaichick V.Y., Tsyb A.F., Vtyurin B.M. Trace elements and thyroid cancer. Analyst. 120:1995;817-821.
61. Köhrle J., Schuppert F., Fekete E., Dreher I. Divergent expression of the selenoproteins type I 5'-deiodinase and glutathione peroxidase in human thyroid tissues. Exp. Clin. Endocrinol. Diabetes. 104:1996;17.
62. Bermano G., Nicol F., Dyer J.A., Sunde R.A., Beckett G.J., Arthur J.R., Hesketh J.E. Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J. 311:1995;425-430.
63. Howie A.F., Walker S.W., Akeson B., Arthur J.R., Beckett G.J. Thyroidal extracellular glutathione peroxidase: a potential regulator of thyroid hormone synthesis. Biochem. J. 308:1995;713-717.
64. Ursini F., Maiorino M., Brigelius-Flohé R., Aumann K.D., Roveri A., Schomburg D., Flohé L. Diversity of glutathione peroxidases. Methods Enzymol. 252:1995;38-53.
65. Howie A.F., Arthur J.R., Nicol F., Walker S.W., Beech S.G., Beckett G.J. Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling pathway. J. Clin. Endocrinol. Metab. 83:1998;2052-2058.
66. Björnstedt M., Kumar S., Björkhem L., Spyrou G., Holmgren A. Selenium and the thioredoxin and glutaredoxin systems. Biomed. Environ. Sci. 10:1997;271-279.
67. Behne D., Hilmert H., Scheid S., Gessner H., Elger W. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta. 966:1988;12-21.
68. Chanoine J.P., Braverman L.E., Farwell A.P., Safran M., Alex S., Dubord S., Leonard J.L. The thyroid gland is a major source of circulating T3 in the rat. J. Clin. Invest. 91:1993;2709-2713.
69. Glattre E., Thomassen Y., Thoresen S.O., Haldorsen T., Lund-Larsen P.G., Theodorsen L., Aaseth J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int. J. Epidemiol. 18:1989;45-49.
70. Aaseth J., Glattre E. The janus study- the role of trace elements in the pathogenesis of thyroid cancer. Full text proceedings and Voice Recording of Presentations and Discussion 'Thyroid and Trace Elements', 6th Thyroid Symposium, Graz Austria. Braverman L.E, Köhrle J, Eber O, Langsteger W. 1996;180-184 CD-ROM Blackwell Wissenschaft, Graz, Austria.
71. Köhrle J. Non-thyroidal health hazards of selenium deficiency. Full Text proceedings and Voice Recording of Presentations and Discussion 'Thyroid and Trace Elements', 6th Thyroid Symposium, Graz, Austria. Braverman L.E, Köhrle J, Eber O, Langsteger W. 1996;58-73 CD-ROM, Blackwell Wissenschaft, Berlin.
72. Contempré B., Vanderpas J., Dumont J.E. Cretinism, thyroid hormones and selenium. Mol. Cell. Endocrinol. 81:1991;C193-C195.
73. Contempré B., Dumont J.E., Bebe N., Thilly C.H., Diplock A.T., Vanderpas J. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab. 73:1991;213-215.
74. Contempre B., Dumont J.E., Denef J.F., Many M.C. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur. J. Endocrinol. 133:1995;99-109.
75. Contempre B., LeMoine O., Dumont J.E., Denef J.F., Many M.C. Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor β (TGF-β). Mol. Cell. Endocrinol. 124:1996;7-15.
76. Denef J.F., Many M.C., van den Hove M.F. Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism? Mol. Cell. Endocrinol. 121:1996;101-103.
77. Dreher I., Köhrle J. Studies on the activation of the nuclear transcription factors NF-κB and AP1 in cultured FRTL5 rat thyroid cells. Exp. Clin. Endocrinol. Diabetes. 104:1996;15.
78. Dreher I. Molekularbiologische Untersuchungen eukaryontischer Selenoproteine und Charakterisierung des humanen Selenoprotein P-Promotors. 1997;PhD Thesis, University of Wuerzburg, Germany.
79. Kikumori T., Kambe F., Nagaya T., Imai T., Funahashi H., Seo H. Activation of transcriptionally active nuclear factor-κB by tumor necrosis factor- and its inhibition by antioxidants in rat thyroid FRTL-5 cells. Endocrinology. 139:1998;1715-1722.
80. Goyens P., Golstein J., Nsombola B., Vis H., Dumont J.E. Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism. Acta Endocrinol. 114:1987;497-502.
81. Hesse-Bähr K., Dreher I., Schmutzler C., Meissner-Weigl J., Köhrle J. Eigenschaften von Selenoprotein P aus der humanen Leberkarzinm-Zellinie HepG2. Reichlmayr-Lais A.M. Schriftenreihe der Gesellschaft für Mineralstoffe und Spurenelemente Wissenschaftliche Verlagsgesellschaft, Stuttgart. 1999;. in press.